Moreover, the results proved that injection of MSCs via an adenoviral vector expressing human IL-2 boosted anticancer effects and increased overall survival rates in tumour-bearing murine models, suggesting that MSCs can be used as cytokine delivery vehicles in anticancer therapy (44). The gene discussed is IL2; the disease is neoplasm.